Findings

What do systematic reviews say?

1,741 questions · 1,821 findings · 207 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 297 · 16.3%GRADE not reported 191 · 10.5%Very low 333 · 18.3%Low 466 · 25.6%Moderate 414 · 22.7%High 120 · 6.6%

Antihypertensive pharmacotherapy vs control

Sudden cardiac death · patients with hypertension

Antihypertensive pharmacotherapy showed no clear difference in sudden cardiac death ( compared with control (moderate certainty).

1 finding from 1 review

Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals 2016 · Cochrane Headline outcomes only
RR 0.96 [0.81, 1.15]
15 studies · 39908 participants
Moderate

Antihypertensive pharmacotherapy vs control

Non‐fatal MI · patients with hypertension

Antihypertensive pharmacotherapy probably leads to lower non‐fatal myocardial infarction ( compared with control (moderate certainty).

1 finding from 1 review

Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals 2016 · Cochrane Headline outcomes only
RR 0.85 [0.74, 0.98]
15 studies · 39908 participants
Moderate

Antihypertensive pharmacotherapy vs control

Fatal myocardial infarction ( · patients with hypertension

Antihypertensive pharmacotherapy probably leads to lower fatal myocardial infarction ( compared with control (moderate certainty).

1 finding from 1 review

Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals 2016 · Cochrane Headline outcomes only
RR 0.75 [0.62, 0.9]
15 studies · 39908 participants
Moderate

Intervention not reported

Systolic blood pressure · Adults with primary hypertension

1 finding from 1 review

Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension 2015 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 1007 participants
Low

Intervention not reported

Diastolic blood pressure · Adults with primary hypertension

1 finding from 1 review

Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension 2015 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 1007 participants
Low

Intervention not reported

Heart rate · Adults with primary hypertension

1 finding from 1 review

Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension 2015 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 977 participants
Low

Intervention not reported

Pulse pressure · Adults with primary hypertension

1 finding from 1 review

Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension 2015 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 1007 participants
Very low

Intervention not reported

WDAE · Adults with primary hypertension

1 finding from 1 review

Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension 2015 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 1412 participants
Moderate

Community ambulation intervention vs other interventions

Participation · adult stroke survivors

1 finding from 1 review

Interventions for improving community ambulation in individuals with stroke 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 198 participants
Low

Community ambulation intervention vs other interventions

Community Walk Test Community walk test (time multiplied by level of walking aid) · adult stroke survivors

1 finding from 1 review

Interventions for improving community ambulation in individuals with stroke 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 45 participants
Low

Community ambulation intervention vs other interventions

Walking ability · adult stroke survivors

1 finding from 1 review

Interventions for improving community ambulation in individuals with stroke 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 45 participants
Low

Community ambulation intervention vs other interventions

Activity Gait speed · adult stroke survivors

1 finding from 1 review

Interventions for improving community ambulation in individuals with stroke 2015 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 98 participants
Low

Community ambulation intervention vs other interventions

Six‐minute walk distance · adult stroke survivors

1 finding from 1 review

Interventions for improving community ambulation in individuals with stroke 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 55 participants
Low

Community ambulation intervention vs other interventions

Self‐efficacy Activities Specific Balance Confidence Scale (0 to 100) and Falls Efficacy Scale (0 to 130) · adult stroke survivors

1 finding from 1 review

Interventions for improving community ambulation in individuals with stroke 2015 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 97 participants
Low

Angiotensin receptor blockers (ARBs) vs conventional therapy

Diastolic blood pressure · patients receiving PD

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 110 participants
Moderate

Angiotensin receptor blockers (ARBs) vs conventional therapy

Serum potassium · patients receiving PD

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 44 participants
Low

Angiotensin receptor blockers (ARBs) vs conventional therapy

Peritonitis · patients receiving PD

Angiotensin receptor blockers (ARBs) showed no clear difference in adverse events (episodes of peritonitis) compared with conventional therapy (low certainty).

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
RR 0.67 [0.18, 2.54]
1 study · 34 participants
Low

Angiotensin‐converting enzyme inhibitors vs conventional therapy

Anuria · patients receiving PD

Angiotensin‐converting enzyme inhibitors (ACEi) probably leads to lower anuria compared with conventional therapy (moderate certainty).

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
RR 0.32 [0.11, 0.94]
1 study · 60 participants
Moderate

Angiotensin‐converting enzyme inhibitors vs conventional therapy

All‐cause mortality · patients receiving PD

Angiotensin‐converting enzyme inhibitors (ACEi) showed no clear difference in mortality compared with conventional therapy (moderate certainty).

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
RR 1.5 [0.27, 8.34]
1 study · 60 participants
Moderate

Angiotensin‐converting enzyme inhibitors vs conventional therapy

Cardiac events · patients receiving PD

Angiotensin‐converting enzyme inhibitors (ACEi) showed no clear difference in cardiac events compared with conventional therapy (moderate certainty).

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in… 2014 · Cochrane Headline outcomes only
RR 1 [0.37, 3.21]
1 study · 60 participants
Moderate